Gout is a relatively common metabolic disease. There are many drugs available for the clinical treatment of gout. In the acute phase of the disease, the drugs are mainly used to inhibit the inflammatory response and relieve the patient’s joint pain, while in the remission phase of the disease, the drugs are mainly used to reduce blood uric acid. In the acute phase: the commonly used drugs are non-steroidal anti-inflammatory drugs, colchicine and glucocorticoids. Because of the acute phase of the disease, the main purpose is to relieve pain and suppress the inflammatory response, so the dosage and duration of these drugs need to be controlled by the clinician. The main purpose of treatment is to maintain the blood uric acid level and prevent the acute attack of gout, so oral uric acid-lowering drugs are needed. There are two main types of drugs commonly used: xanthine oxidase inhibitors, and drugs that promote uric acid excretion. In daily life, some patients also choose sodium bicarbonate to alkalize the urine, which is an adjunct to treatment, but has no therapeutic effect on the disease itself. Gout is a chronic, lifelong disease that needs to be taken seriously by patients and treated aggressively. But the disease is a metabolic disease, in addition to drug treatment, more attention is paid to daily life, such as reducing excessive intake of high purine foods, reducing weight, reducing strain, avoiding further aggravation of joint damage, etc.